Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial

BACKGROUND—: This randomized controlled trial evaluated clinical durability of Zilver PTX, a paclitaxel-coated drug-eluting stent (DES), for femoropopliteal artery lesions. Outcomes compare primary DES versus percutaneous transluminal angioplasty (PTA), overall DES (primary and provisional) versus s...

Descripción completa

Detalles Bibliográficos
Autores principales: Dake, Michael D., Ansel, Gary M., Jaff, Michael R., Ohki, Takao, Saxon, Richard R., Smouse, H. Bob, Machan, Lindsay S., Snyder, Scott A., O’Leary, Erin E., Ragheb, Anthony O., Zeller, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823823/
https://www.ncbi.nlm.nih.gov/pubmed/26969758
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.016900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823823/
https://www.ncbi.nlm.nih.gov/pubmed/26969758
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.016900

Ejemplares similares